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CANADIAN SPEAKER
Jennifer A. Oranget
Thanks very much, Sara. That was very helpful in setting the stage for my
presentation, which is on the Canadian perspective on cross-border pharma-
ceutical trade, in particular on the rise of Internet pharmacies over the last
several years.
First, I want to thank you for inviting me to speak to you today. I am
really honored to be here. I am going to review the background of the rise of
Internet pharmacies and look at the regulatory framework in Canada that has
allowed them to be profitable. I will look at the arguments for and against the
pharmacies from the Canadian perspective, what the regulators are doing,
and what they may do in the future to curtail the growth of Internet pharma-
cies.
Just one small anecdote: This morning I met a friend for coffee, whom I
have not seen for some time. She recently moved back home to Cleveland.
She asked me what I was speaking about today, and when I told her, she said,
"Oh, that is funny. I just ordered some drugs online from Canada last week."
And she works in the healthcare industry, so this got me thinking. Since I
think most of the people in this room are Americans, I will not be so bold as
to ask you whether you have ordered drugs online, but I was wondering if
you could raise your hand if you know someone who has ordered drugs on-
line from Canada.
(Large number of hands raised - laughter.)
There are a fair number of people here who know someone who has done
so. Before the popularity of Internet pharmacies, the U.S. and Canadian mar-
kets operated in two separate spheres. The United States uses market prices,
and Canada has price controls on its drugs, with the maximum price for a
patented drug in Canada set by the PMPRB, an acronym for the Patented
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Medicines Prices Review Board.' The PMPRB sets this price by taking
prices in seven western industrialized countries and using the median price
for any single drug. 2 It is notable that these countries have high living stan-
dards and very well regulated health services and health systems. We are
talking about the United Kingdom, France, Germany, Italy, Switzerland,
Sweden, and the United States. So these are not countries with inexpensive
drugs, but because Canada takes the median price, its drug price will never
be the highest. Although Sara has referred to the minimal cost savings of
online drugs, the Canadian price will typically be somewhat less than the
U.S. price.3
The Internet pharmacies capitalize on this difference between the Cana-
dian and U.S. prices by using a price in between the two.4 In 2001, we started
to see the surge of Internet pharmacies, and by 2002, they were doing $400
million worth of business. 5 In 2004, it was reported that these pharmacies did
$850 million worth of business.6 Reports about the volume of business differ.
Some people think that this $850 million is a plateau and will not go any
higher, 7 but if the United States actually legalizes the importation of Cana-
dian drugs, or if other states or municipalities further encourage their citizens
and employees to import drugs from Canada, we could see further growth in'
the area.
Although it is illegal in the United States to bring in prescription drugs
from Canada, there is a "personal use exemption." An individual can import
90 days worth of drugs for his or her own use,8 and Internet pharmacies tend
to sell drugs in 90-day amounts.9 Although there may be only minimal cost
1 Dr. Carlyle Farrell, Canadian e-Pharmacies - Ethics, Law, Politics and the Death of
Free Enterprise, (Ryerson University School of Management, Toronto), March 2005, at 2.
2 See Patented Medicines Price Review Board, Frequently Asked Questions, How Does
the PMARB Review the Pricing Information for all Patented Medicines Sold in Canada?,
http://www.pmprb-cepmb.gc.ca/english/view.asp?x=272#16.
3 See generally Patented Medicines Price Review Board, Frequently Asked Questions
How do Drug Prices in Canada Compare to Prices in Other Countries?, http:/Iwww.pmprb-
cepmb.gc.ca/english/view.asp?x=272# 14.
4 See generally Consumer Reports, Prescription Drugs, The Facts about Canada,
http://www.consumerreports.org/cro/personal-fmance/prescription-drugs-from-canada-
1005/overview.htm
(Oct. 2005).
5 See generally Graeme Smith, Any Drug Shortages Manageable, Generic Firms Say,
GLOBE AND MAIL (Toronto), Nov. 1, 2003, at A4.
6 Susan Todd, Canada Mulls Limiting Exports of Affordable Medicines, NEWHOUSE NEWS
SERVICE, available at http://www.newhousenews.com/archive/todd021405.html (Feb. 14,
2005).
7 See generally id.
8 Ted Sickinger, Internet Prescription Sales Fly Not Quite Under the Radar, THE
OREGONIAN (Portland), Oct. 16, 2005.
9 See generally id.
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savings for some drugs, for others, the numbers are significant. The price for
Clarinex, the allergy drug, is $27 in Canada, and $70 in the United States.
10
For Lipitor, a very popular cholesterol-reducing drug, the price is $144 in
Canada, and $200 in the United States. 1 And for some drugs, the price dif-
ference is quite striking. Tamoxifen (Nolvadex), a breast cancer fighting
drug, is almost $300 cheaper in Canada.' 2 So for certain drugs, especially
those for long-term use, such as Lipitor, you can see why people are search-
ing online to get these cost savings.
One interesting note: Americans who are going online to buy drugs are
not the poor. It is not the poor American who is getting these cost savings.
Surveys have shown that it is upper-middle-class Americans who are buying
drugs online. 13 They are the people who have ready access to the Internet.
They are computer savvy, and they are out there saving their money.
Within Canada, we have heard a lot of criticism about Internet pharma-
cies, but there is a strong lobby supporting Internet pharmacies. An argument
in favor of Internet pharmacies is that this is a strong local business, which
began in Manitoba, and now employs about 4000 people. 14 The other favor-
able argument we hear is that Canadian drugs are safe.' 5 Canada has a highly
regulated healthcare system, and although there are always some risks in
transporting drugs, Canadian drugs are safe. 16 However, more recently, Ca-
nadian regulators have been highly critical of Internet pharmacies. The pri-
mary issues being that Canadians are going to face drug shortages and an
increase in drug prices. 17
The concern over drug shortages arose in the fall of 2004, after a shortage
of the flu vaccine in the United States. Canadians were worried there would
be a run on the vaccine in Canada, leading to a domestic shortage. 8 Fortu-
nately, that did not happen. Internet pharmacies do not sell wholesale in bulk
10 Justin Thompson, In-depth: Drugs Cross-Border Rx, CBC NEWS ONLINE,
http://www.cbc.ca/news/background/drugs/ (Aug. 12, 2004).
l2 Id.
13 See generally Melissa Lambert Milewski, Drug Importation Carries Unseen Risks,
Washington Policy Center,
http://www.washingtonpolicy.org/HealhCare/OPEDMilewskiDruglmportationApr2004.htm
(Apr. 28, 2004).
14 Dr. Carlyle Farrell, Canadian e-Pharmacies - Ethics, Law, Politics and the Death of
Free Enterprise, (Ryerson University School of Management, Toronto), March 2005, at 2.
15 See CanadaDrugs.com, Welcome to Canadadrugs.com, http://www.canadadrugs.com/
16 See generally id.
17 Thompson, supra note 10.
18 Public Health Agency of Canada, Frequently Asked Questions - Influenza Vaccine
Shortage in the United States, http://www.phac-aspc.gc.ca/influenza/vaccine-faq_e.html (Oct.
24, 2004) [hereinafter Influenza Vaccine Shortage in the United States].
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to physicians in the United States; they sell to individuals.' 9 Since the vac-
cine has to be administered by a doctor, there was no mass export of flu vac-
cine from Canada. 20 But we can imagine a situation where some day the flu
vaccine is in the form of a pill that you can order online, and the United
States has a similar shortage, prompting mass orders that lead to a drug
shortage in Canada. For now, it is unclear whether there have been drug
shortages. Some pharmacists, particularly in areas where there are a lot of
Internet pharmacies, have reported that they have had trouble getting certain
drugs.2' Other pharmacists in similar areas have said that they have been able
22to source them. So it is not clear whether we have actually run into supply
problems. Diane Gorman, Assistant Deputy Minister of the Health Products
and Food Branch of Health Canada, did say that cross-border sales of pre-
scription drugs via the growing business of Internet pharmacies raises the
potential for drug shortages domestically.2 3 Health Canada regards this as a
very serious matter due to the inherent risk to Canadians' health. So it is a
concern, and it is at the forefront of most Canadian consumers' minds.
It is also difficult to know for certain whether there have been price in-
creases as a result of Internet pharmacies. It was reported that in 2004, Cana-
24dian pharmaceutical prices increased for the first time in a decade. There
are many factors that go into the price of pharmaceuticals, 25 so it is hard to
know if the Internet pharmacy trend is one factor; but it might be more than a
coincidence when $850 million worth of sales took place last year.26 It will
be interesting to watch in the next few years, to see if the trend continues.
In addition to supply and price issues, Canadian regulators have seen In-
ternet pharmacies as posing health and safety concerns, which is interesting
because that also seems to be the U.S. concern. To get a prescription drug
from Canada, you have to fax an American doctor's prescription to the Ca-
nadian Internet pharmacy. The Internet pharmacy then needs a Canadian
doctor to sign that prescription because in Canada, a foreign prescription is
19 See generally Robert McMillan, Canada: Down on the Pharm, Washington Post, July 1,
2005, http://www.washingtonpost.com/wp-
dyn/content/article/2005/07/01/AR200507010061 i.html.20 See generally Influenza Vaccine Shortage in the United States, supra note 18.
21 Press Release, Canadian International Pharmacy Association, Canadian International
Pharmacy Association Requests Evidence of Alleged Drug Shortage in Canada (Nov. 21,
2003) http://www.ciparx.ca/art-cipa-requests-evidence.html.
22 See id.
23 Internet Pharmacies Could Lead to Drug Shortage: Official, CBC NEWS, (Oct. 29,
2003).
24 See Thompson, supra note 10.
25 Patented Medicines Price Review Board, Frequently Asked Questions, What factors
affect the cost of prescription medicines?, http://www.pmprb-
cep6mb.gc.ca/english/view.asp?x=272# 13.
Todd, supra note 6.
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not valid. So the Internet pharmacy hires a Canadian doctor to "co-sign," or
"countersign" the prescription. The Canadian doctor reads the prescription
and signs off.27 Then the pharmacists can fill the prescription and send the
drug to the American client.
However, Canadian doctors are signing prescriptions without ever meet-
ing the patient. So from a health and safety perspective in Canada, they are
not following the "principle of assessment and diagnosis,,, 28 which is some-
thing we are all familiar with from our visits to the doctor. The doctor takes
your history, conducts a physical examination, and asks you a few questions.
The doctor then comes to a conclusion, offers you a prescription, and says,
"If it does not clear up within the next week, or you have the following side
effects, give me a call." So Canadian doctors are not following basic prac-
tices in their own discipline. This has led to a strong statement by our health
minister: "The practice of countersigning prescriptions by doctors without
actually having a relationship with the patient, and not properly assessing the
patient, is absolutely unethical and unprofessional." This calls into question
the integrity of our own health system if our doctors are not following these
basic practices.
Now that we have looked at some of the concerns of Canadians regarding
Internet pharmacies, let us look at who could regulate this system. I have set
out a chain of parties that may be involved in this system, which is not com-
plete by any means. We have American patients, and obviously, we have
American doctors. We have the web providers, such as Microsoft Internet
Explorer and Google. These provide access to the Internet, which in turn
provides access to Internet pharmacies.
In addition, we have the pharmaceutical companies, both the manufactur-
ers and the suppliers of the drug; the pharmacies, the businesses themselves
in Canada; Canadian doctors; and shippers, such as Canada Post, UPS,
FedEx, who play a major role. Americans received about 2 million packages
29
of drugs last year, so this is big business for the shippers. And finally, we
have the Canada Customs and Revenue Agency.
What can the regulators do about Internet pharmacies? It is a complicated
system and, in March 2005, our health minister said that he is nowhere near a
decision on how to restrict Internet pharmacies. Despite his indecision, there
has been some movement in the last twelve months, and it has been mostly
against the regulated professions: doctors and pharmacies. 30 There is also a
27 See California Healthcare Foundation, iHealthBeat, Regulators Focus on Canadian
Internet Pharmacies, http://www.ihealthbeat.org/index.cfin?Action=dspltem&itemlID=1 07928
(Dec. 13, 2004) [hereinafter Regulators Focus on Canadian Internet Pharmacies].
28 See id.
29 Thompson, supra note 10.
30 See generally Todd, supra note 6.
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potential for regulation regarding customs and exports. 31 The public moved
against the doctors first,32 and the doctors' own association took the strongest
action early last year.33 The Canadian Medical Protective Association is an
association that, among other things, helps doctors defend themselves against
lawsuits. It announced in February 2004, that it will no longer assist physi-
cians in legal actions arising from inappropriate co-signing. 34 Assistance will
not be extended, regardless of where the action is launched, inside or outside
Canada's borders. So with the litigiousness of the American public, and
higher damage awards in the United States, this could cause a lot of stress for
some co-signing physicians in Canada, who are regulated by the provincial
Colleges of Physicians and Surgeons.
Recently, the Colleges of Manitoba, New Brunswick, British Columbia,
and Ontario, have taken disciplinary action against doctors.35 Quebec and
Alberta have also taken some action, but they have really only just been able
to prosecute a handful of doctors, and the penalties that they have imposed
have been meager. 36 The most severe penalties we have seen are those in
New Brunswick, which fined one doctor $25,000. 3 7 The harshest penalty was
suspending a doctor from practicing for two years. 38 But few doctors have
been prosecuted. In Ontario, four doctors have been prosecuted, and they
have all received mere reprimands.3 9 There has been no significant fine.4 °
The courts have awarded legal costs, the highest amount being $5,000
against a doctor who made over $200,000 in six months just from co-signing
41 . 42prescriptions. He made $10 a prescription. So it is somewhat disturbing
that the colleges have not been able to take more aggressive action against
members of their profession.
31 Id.
32 See generally Regulators Focus on Canadian Internet Pharmacies, supra note 27.
33 See Canadian Docs Who Co-Sign Rx Left Without Coverage, US DEPT OF HEALTH AND
HUMAN SERVICES: INDIAN HEALTH SERVICE, http://www.ihs.gov/Medical Pro-
grams/Pharmacylssues/Acquisitions/l 19_ 04.asp.
34 See id.
35 See Lisa Priest, Doctors in Hot Water Over Web Prescriptions, GLOBE AND MAIL, Octo-
her 11, 2004, at Al.
3" See id.
37 Id.
38 Marguerite Higgins, Canada Prescribes Penalty for Doctor, THE WASHINGTON TIMES,
February 3, 2005.
39 See Priest, supra note 35, at Al.
40 See id.
41 James Rusk, MD Fined $5,000 for Net Drugs Role; Ontario College Too Easy on Doc-
tor Who Signed U.S. Prescriptions, Critic Says, GLOBE AND MAIL, March 11, 2005, at A11.
42 id.
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We are also seeing some action by the colleges of pharmacies 43 - for ex-
ample, the Manitoba Pharmaceutical Association says it plans to take action
against pharmacies that do not follow provincial medical standards. 44 This
would mean that if a pharmacist gets a U.S. prescription that a Canadian doc-
tor has just co-signed, the pharmacist is not to fill it. The prescription would
not meet Canadian medical standards. But again, it is taking some time to get
the regulatory ball rolling.
The customs and export arena offers potential for helpful regulation, al-
though the options may be somewhat problematic under NAFTA. 45 One op-
tion is to use export restrictions under the Export and Import Permits Act,
which can restrict which drugs are exported to the United States, or restrict
the exports of price-controlled drugs - those drugs under the PMPRB's area
of jurisdiction.46 Another potential course of action would be to create a list
of drugs that would be banned if shortages actually did occur. Any absolute
export restriction would be challengeable under NAFTA. The third option
may be able to survive a NAFTA challenge if Canada could show that there
was a health and safety concern in the event of a drug shortage that needed to
be addressed for the health and safety of Canadians. At this point, however,
we do not have any indication of how Health Canada may proceed.
While the governmental entities have been acting slowly on these issues,
private actors have been swifter. As we can imagine, the pharmaceutical
companies are very concerned about this issue and have brought lawsuits
against Internet pharmacies,47 especially where the companies find an illegal
version of the drug being sold.48 Pharmaceutical companies for approxi-
mately the last year and a half have been limiting supply to wholesalers that
43 See Nat'l Ass'n of Bds. of Pharmacy, Position Paper on the Importation of Foreign
Prescription Drugs (March 2003), available at
htt ://www.nabp.net/ftpfiles/NABP01/foreigndrug.pdf.
Canadian Health Minister Welcomes Pharmaceutical Assoc's Action Against Pharma-
cists, MEDICAL NEWS TODAY, December 5, 2004.
45 See generally John R. Graham, Prescription Drug Prices in Canada and the United
States - Part 4: Canadian Prescriptions for American Patients Are Not the Solution, PUBLIC
POLICY SOURCES, September 2003, available at
http://www.fraserinstitute.ca/admin/books/files/PDP4John.pdf (evaluating various prescription
drug policies from a free trade perspective).
4 See Martin O'Hanlon, HL: Canada Considers Banning Sale of Cheap Patented Drugs to
U.S., AP Alert - Bus. 21:04:25, February 18, 2005; see also generally Drug Patents and Drug
Prices: The Role of the PMPRB, Patented Medicine Prices Review Board, http://www.pmprb-
cepmb.gc.ca/English/view.asp?x=134&mid=71 (provides overview of the PRMPB's role and
jurisdiction).
47 See e.g., Press Release, Pfizer, Unlicensed and Illegal Online 'Pharmacies' Deceive
Consumers, Intrude on Their Privacy and Pose Public Health and Financial Risks, August 3,
2004, available at http://www.pmewswire.com/cgi-
bin/stories.pl?ACCT=104&STORY=/www/story/08-03-2004/0002223913 &EDATE=.
48 See id.
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sell to Internet pharmacies as a way of cutting off the supply at the source.
49
They are not limiting supply to regular pharmacies that are legitimately serv-
ing the Canadian public, but to Internet pharmacies that are then exporting
the drugs to the United States.
It will also be interesting to follow discussions about the use of technol-
ogy to trace the flow of drugs coming from the pharmaceutical companies.
Internet pharmacies themselves are considering establishing a self-regulated
standard5" so that when customers come across the standard, they will know
that this Internet pharmacy is following certain regulations, is not breaking
any laws, and is legitimate. But for now, that standard would mean that the
Internet pharmacy is not exporting drugs to the United States. The standard
would be used only for Internet pharmacies that sell exclusively to their own
nationals.
Canada is clearly grappling with how it can limit the cross-border trade of
drugs through Internet pharmacies, but the Internet pharmacies keep going.
David McKay, a very outspoken Executive Director of the Canadian Interna-
tional Pharmaceutical Association (the association that represents Internet
pharmacies), stated: "We are like the mosquito that they cannot seem to
kill."5' This is not the most flattering self-description I have ever heard, but
he is right. They keep on surviving, and the drugs keep flowing from Canada
to the United States. And if, for some reason, they are stopped, and Canadian
Internet pharmacies can no longer sell drugs to Americans, I have no doubt
that American consumers will continue to find low-price pharmaceutical
drugs from further afield.
Thank you.
49 See Tom Cohen, Internet Drug Firms Ailing Big Drug Makers Strangling Supplies to
Stifle Upstarts, GLOBE AND MAIL, September 2, 2003, at B12.
50 See e.g., Nat'l Ass'n of Pharmacy Regulatory Authority, Verified Internet Pharmacy
Practice Sites (VIPPS) Letter of Agreement, available at
http://www.napra.caVIPPSsite/forms/0307letterofagreement.pdf (laying out the agreement
between the Canadian regulatory body and the association representing Canadian pharmacies).
51 Priest, supra note 35, at Al.
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